Outsourced Pharma Webinars

  1. Smarter Development Of Chromatography Processes – Reducing Timelines And Improving Outcomes
    10/10/2019

    Time to experiment, time to clinic, and time to market is becoming even more important for developers and manufacturers of biopharmaceuticals. At the same time, the amount of data enclosed in biologic license applications are more comprehensive to avoid extended review. In this webinar we will review three fields that enable reduced timelines and improved outcomes of process development activities.

  2. Capture OTC Market Share For Geriatric And Pediatric Patients
    8/15/2019

    This webinar discusses how the unique properties of gelatin have been used to develop chewable softgel formulations for the pediatric and geriatric patient populations. 

  3. Why Are Lipid Formulations Commonly Used To Enhance Bioavailability?
    8/15/2019

    Thermo Fisher Scientific's Kaspar van den Dries and Helena Teles discuss potential mechanisms of increased absorption with lipid formulations and appropriate screening tools that are used during the development approach of these formulations, as well as scale up and industrialization considerations. 

  4. Venerated And Vital: Using Lipid Based Delivery For Fast And Efficient Early Phase Development
    7/17/2019

    Introduced to the pharmaceutical industry decades ago, lipid-based drug delivery systems are the most well-studied and widely utilized technology among all available bioavailability enhancement technologies. Lipid-based drug delivery systems have delivered more than 60 unique drug molecules to market – and counting. Watch this webinar to learn more about the importance of and recent developments in lipid-based drug delivery systems, novel lipid excipients, models, and screening tools for early phase development of lipid-based drug delivery systems, and using mechanistic studies and modeling to predict the impact of lipids on oral absorption.

  5. Standing Out In The Crowded Biopharma CDMO Market
    3/14/2019

    When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time. 

  6. A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry
    12/11/2018

    This presentation discusses the basic definitions of extractables and leachables, including details from a case study done using prefilled syringes and a second using a single-use bag.

  7. Cell-Based Assays In A GMP Environment: Approaches For Clinical And Commercial Stability Studies
    12/11/2018

    This presentation demonstrates that in vitro, cell-based assays is an indispensable tool to quantify the biological activities, and to support the potency tests, for bio therapeutics.

  8. Optimizing Your Plate-Based Assay Workflows
    11/27/2017

    Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.

  9. Leveraging Machine Learning For Decision Making In The Lab
    11/27/2017

    This webinar explores use cases showing how machine learning and analytics can help overcome the challenges facing the biopharma industry through more confident data-driven decisions.

  10. Looking Under The Hood Of The Unified Lab
    11/22/2017

    Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.